Drug Shortage Report for AURO-VALSARTAN HCT

Last updated on 2021-02-19 History
Report ID 99837
Drug Identification Number 02408155
Brand name AURO-VALSARTAN HCT
Common or Proper name Hydrochlorothiazide; valsartan
Company Name AURO PHARMA INC
Market Status MARKETED
Active Ingredient(s) HYDROCHLOROTHIAZIDE VALSARTAN
Strength(s) 25MG 320MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100s, 30
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-11-25
Estimated end date 2021-02-19
Actual end date 2021-02-18
Shortage status Resolved
Updated date 2021-02-19
Company comments Auro-Valsartan HCT 25mg/320mg (100's) available as of February 18, 2021 Auro-Valsartan HCT 25mg/320mg (30's) - Replaceable with Auro-Valsartan HCT 25mg/320mg (100's)
Health Canada comments
Tier 3 Status No
Contact Address 3700 STEELES AVENUE WEST, SUITE 402
WOODBRIDGE, ONTARIO
CANADA L4L 8K8
Company contact information Balaji Srinivasan

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v22 2021-02-19 English Compare
v21 2021-02-18 French Compare
v20 2021-02-18 English Compare
v19 2021-02-18 English Compare
v18 2021-02-12 French Compare
v17 2021-02-12 English Compare
v16 2021-02-03 French Compare
v15 2021-02-03 English Compare
v14 2021-01-20 French Compare
v13 2021-01-20 English Compare
v12 2021-01-08 French Compare
v11 2021-01-08 English Compare
v10 2021-01-08 French Compare
v9 2021-01-08 English Compare
v8 2020-10-23 French Compare
v7 2020-10-23 English Compare
v6 2020-10-14 French Compare
v5 2020-10-14 English Compare
v4 2020-09-11 French Compare
v3 2020-09-11 English Compare

Showing 1 to 20 of 22